A clinical trial by Singapore Eye Research Institute (SERI) and Singapore Chung Hwa Medical Institution (SCHMI) is recruiting peri- and post-menopausal women to evaluate the efficacy of traditional Chinese medicine (TCM) remedies for treating dry eye.

A clinical trial has been approved in Singapore to study the use of traditional Chinese medicine Lianhua Qingwen in treating adults with mild COVID-19.
The study, approved on Jan 18, was initiated by the Singapore Chung Hwa Medical Institution, said the Health Sciences Authority (HSA) in response to CNA's queries on Tuesday (Apr 19).